Evidence map›Paper›PMID 9060691›Full record

ArticleJournal of virology1997

Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).

O Pleskoff, N Sol, B Labrosse, M Alizon

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. The variants question: What is the problem?Journal of medical virology · 2021
    Review
  2. Article
  3. Article
  4. Review
  5. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2001
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

O PleskoffINSERM U.332, Institut Cochin de Génetique Moleculaire, Paris, France.
N Sol
B Labrosse
M Alizon
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A clade B strain of human immunodeficiency virus type 1 (HIV-1(LAI)) could infect CD4+ cells expressing human CXCR-4 (fusin) or its rat homolog with similar efficacy. By contrast, cells expressing rat CXCR-4 were not permissive to HIV-1(NDK) (clade D), HIV-2(ROD), or HIV-1(LAI) with chimeric envelope protein gp120 bearing the V3 domain from HIV-1(NDK). The reciprocal chimeric gp120 (HIV-1(NDK) with V3 from HIV-1(LAI)) could mediate infection of cells expressing either human or rat CXCR-4. Genetically divergent HIV strains have different requirements for interaction with the CXCR-4 coreceptor, and the gp120 V3 domain seems to be involved in this interaction.

Indexed as

AnimalsCD4-Positive T-LymphocytesHeLa CellsHIV-1HIV-2HIV Core Protein p24HIV Envelope Protein gp120HumansMembrane ProteinsPeptide FragmentsRatsReceptors, CXCR4Receptors, HIVRecombinant Fusion ProteinsSpecies SpecificityTumor Cells, CulturedHIV Core Protein p24HIV Envelope Protein gp120HIV envelope protein gp120 (305-321)Membrane ProteinsPeptide FragmentsReceptors, CXCR4Receptors, HIVRecombinant Fusion Proteins

Identifiers

PMID9060691
PMCPMC191460
OpenAlexW2153001355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.